menu
    • menu

    Company profile for Lexeo Therapeutics

    NEW Drugs in Dev: 6
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    LEXEO Therapeutics is a New York City based clinical stage gene therapy biotechnology company with a focus on hereditary and acquired diseases of high unmet need. Founded in 2018 based on 25 years of research at a leading scientific institution, LEXEO's investigational therapies have the potential to offer gene therapy based treatments to address many diseases that have eluded today's existing drug delivery platforms. Our mis...
    LEXEO Therapeutics is a New York City based clinical stage gene therapy biotechnology company with a focus on hereditary and acquired diseases of high unmet need. Founded in 2018 based on 25 years of research at a leading scientific institution, LEXEO's investigational therapies have the potential to offer gene therapy based treatments to address many diseases that have eluded today's existing drug delivery platforms. Our mission at LEXEO is to lead the field of gene therapy as a fully integrated biotechnology company; discovering, developing and delivering treatments and cures to some of today's most devastating diseases

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lexeo TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    430 East 29th Street, 14th Floor, New York, NY 10016
    Telephone
    Telephone
    (212) 547-9879
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.lexeotx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lexeo Therapeutics: Q4 & FY 2025 Results & Operational Highlights
    Lexeo Therapeutics: Q4 & FY 2025 Results & Operational Highlights

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3265004/0/en/Lexeo-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Operational-Highlights.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Lexeo Therapeutics Joins Leerink Global Healthcare Conference
    Lexeo Therapeutics Joins Leerink Global Healthcare Conference

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248217/0/en/Lexeo-Therapeutics-to-Participate-in-the-Leerink-Global-Healthcare-Conference.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    Lexeo Therapeutics Joins February Investor Conferences
    Lexeo Therapeutics Joins February Investor Conferences

    05 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/05/3232877/0/en/Lexeo-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences-in-February.html

    GLOBENEWSWIRE
    05 Feb 2026
    Share Share
    Lexeo Enhances Cardiovascular Team, Expands Cardiac Therapeutics
    Lexeo Enhances Cardiovascular Team, Expands Cardiac Therapeutics

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3226373/0/en/Lexeo-Therapeutics-Announces-Key-Leadership-Appointments-Strengthening-Cardiovascular-Expertise-Alongside-Updates-to-Strategic-Partnership-for-Novel-Cardiac-RNA-Therapeutics.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share
    Lexeo Therapeutics Reports Encouraging Phase I/II Results
    Lexeo Therapeutics Reports Encouraging Phase I/II Results

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216688/0/en/Lexeo-Therapeutics-Announces-Positive-Interim-Phase-I-II-Data-for-LX2020-for-the-Treatment-of-PKP2-Associated-Arrhythmogenic-Cardiomyopathy.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    Lexeo, J&J Team Up On Heart Pump Tech For Gene Therapy Delivery
    Lexeo, J&J Team Up On Heart Pump Tech For Gene Therapy Delivery

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215190/0/en/Lexeo-Therapeutics-Announces-Research-Collaboration-to-Explore-Targeted-Cardiac-Delivery-of-AAV-Gene-Therapy.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search